# EDGAR Filing Document

**Accession Number:** 0001359057
**File Stem:** 0000898531-23-000168
**Filing Date:** 2023-3
**Character Count:** 125596
**Document Hash:** d8f23ae1fbca8fcfc42a921517144802
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000898531-23-000168.hdr.sgml**: 20230317

**ACCESSION NUMBER**: 0000898531-23-000168

**CONFORMED SUBMISSION TYPE**: N-CSR/A

**PUBLIC DOCUMENT COUNT**: 8

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230317

**DATE AS OF CHANGE**: 20230317

**EFFECTIVENESS DATE**: 20230317

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Manager Directed Portfolios
- **CENTRAL INDEX KEY:** 0001359057
- **IRS NUMBER:** 571138125
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** N-CSR/A
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-21897
- **FILM NUMBER:** 23741984

**BUSINESS ADDRESS:**
- **STREET 1:** C/O U.S. BANCORP FUND SERVICES, LLC
- **STREET 2:** 615 E. MICHIGAN STREET
- **CITY:** MILWAUKEE
- **STATE:** WI
- **ZIP:** 53202
- **BUSINESS PHONE:** 9522306140

**MAIL ADDRESS:**
- **STREET 1:** C/O U.S. BANCORP FUND SERVICES, LLC
- **STREET 2:** 615 E. MICHIGAN STREET
- **CITY:** MILWAUKEE
- **STATE:** WI
- **ZIP:** 53202

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Roxbury Funds
- **DATE OF NAME CHANGE:** 20060411

## Series and Classes Contracts Data

### Spyglass Growth Fund (Series ID: S000060175)

| Class ID   | Class Name           | Ticker Symbol   |
|:---|:---|:---|
| C000196940 | Institutional Shares | SPYGX           |

UNITED STATES<br> SECURITIES AND EXCHANGE COMMISSION<br> Washington, D.C. 20549

#### FORM N-CSR

#### CERTIFIED SHAREHOLDER REPORT OF REGISTERED

#### MANAGEMENT INVESTMENT COMPANIES

Investment Company Act file number **<u>811-21897</u>**

**<u>Manager Directed Portfolios</u>**<br> (Exact name of registrant as specified in charter)

#### 615 East Michigan Street
**<u>Milwaukee, WI 53202</u>**<br> (Address of principal executive offices) (Zip code)

#### Scott M. Ostrowski, President

#### Manager Directed Portfolios

#### c/o U.S. Bank Global Fund Services

#### 811 East Wisconsin Avenue, 8<sup>th</sup> Floor
**<u>Milwaukee, WI 53202</u>**<br> (Name and address of agent for service)

<u>(414) 765-4339</u>

Registrant's telephone number, including area code

Date of fiscal year end: **<u>December 31, 2022</u>**

Date of reporting period: **<u>December 31, 2022</u>**

------

**#### Item 1. Reports to Stockholders.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)** 

![](spyglass-logo.jpg)

Spyglass Growth Fund

Annual Report

December 31, 2022

------

#### Spyglass Growth Fund

#### **Table of Contents**

---

| | |
|:---|:---|
| Letter to Shareholders | 3 |
| Investment Highlights | 8 |
| Sector Allocation of Portfolio Assets | 9 |
| Schedule of Investments | 10 |
| Statement of Assets and Liabilities | 12 |
| Statement of Operations | 13 |
| Statements of Changes in Net Assets | 14 |
| Financial Highlights | 15 |
| Notes to Financial Statements | 16 |
| Report of Independent Registered Public Accounting Firm | 25 |
| Expense Example | 26 |
| Statement Regarding Liquidity Risk Management Program | 28 |
| Notice to Shareholders | 29 |
| Trustees and Officers | 30 |
| Approval of the Spyglass Growth Fund Investment Advisory Agreement | 33 |
| Notice of Privacy Policy and Practices | 36 |

---

------

#### Spyglass Growth Fund

#### Letter to Shareholders
(Unaudited)

Dear Shareholders,

For the fiscal year ended December 31, 2022, the Spyglass Growth Fund – Institutional Shares (the "Fund") generated a negative return of 47.23%<sup>(1)</sup>. This performance was unfavorable compared to the negative return of 26.72% for its benchmark, the Russell Midcap Growth Index (which includes the reinvestment of dividends, interest income, and capital gains), and to the negative return of 18.11% for the S&P 500 Index (which includes the reinvestment of dividends, interest income, and capital gains), as a comparison for the broader equity market performance.

The Fund invests in dynamic companies, operating in rapidly growing industries that are being led by results-oriented, entrepreneurial management teams. The Fund's strategy remains consistent as it attempts to identify companies that are benefiting from secular growth and are well positioned to compete in the industries in which they operate.

The Fund's top five performers during 2022 were Twitter, Inc., Ascendis Pharma A/S, TransDigm Group, Inc., Five Below, Inc., and Ulta Beauty, Inc. Two of these five holdings were not in the portfolio at the end of 2022 – Twitter, Inc., which was sold in the second quarter of 2022, and Ulta Beauty, Inc., which was sold in the third quarter of 2022. Twitter, Inc., a leading social media company, was a top performer for the Fund in 2022. Spyglass exited the position in the second quarter of 2022 after a definitive agreement was reached for the Company to be acquired by Elon Musk. Ascendis Pharma A/S, a leading global biopharmaceutical company, was a top performer for the Fund in 2022. The Company's lead asset, SKYTROFA, exceeded expectations throughout the year. Additionally, the Company reported positive clinical data for its TransCon PTH and TransCon CNP clinical programs. TransDigm Group, Inc., a leading global aerospace company, was a top performer for the Fund in 2022. The Company reported solid results throughout its fiscal year and benefitted from growing air traffic volumes around the globe. Five Below, Inc., a value-oriented specialty retailer, was a top performer for the Fund in 2022. Despite a challenging macro environment leading the Company to reduce its initial full year guidance, Five Below reported strong results and accelerating momentum in the second half of the year while continuing to open up more new stores and roll out new growth initiatives. Ulta Beauty, Inc., the largest beauty retailer in the US, was a top performer for the Fund in 2022. Spyglass exited the position in the third quarter of 2022. Spyglass assessed the Company as fairly valued and viewed the risk-reward as relatively balanced, therefore it was deemed prudent to reallocate the capital to more attractive opportunities elsewhere in the portfolio.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  |  |  |  | Since |
|  | One-Year | Three-Year | Five-Years | Inception<sup>(2)</sup> |
| Spyglass Growth Fund – Institutional Shares<sup>(1)</sup> | (47.23%) | (7.17%) | 3.73% | 6.35% |

---

*As of December 31, 2022.*

*<sup>(1)</sup> Performance verified by US Bank Global Fund Services. Past performance does not guarantee future results.*

*<sup>(2)</sup> Inception date October 1, 2015.*

*Three-year, five-year, and since inception performance is annualized.*

------

#### Spyglass Growth Fund

In 2022, the Fund's five biggest detractors were AppLovin Corporation, Affirm Holdings, Inc., Lyft, Inc., Momentive Global Inc., and Peloton Interactive, Inc. AppLovin Corporation, a leading software solutions provider for app developers, was a bottom contributor for the Fund in 2022. Industry-wide headwinds weighed on the growth of the mobile app ecosystem as the year progressed, thereby reducing the willingness of app developers to spend on user acquisition and limiting the AppLovin's revenue potential. Affirm Holdings, Inc., a leading financial technology company, was a bottom contributor for the Fund in 2022. Despite an overall healthy demand environment, ongoing interest rate hikes impacted the Company's go-forward growth rate, ultimately leading it to lower its fiscal year 2023 growth expectations. Lyft, Inc., a leading ride-sharing company, was a bottom contributor for the Fund in 2022. Investors were disappointed with Lyft's investments in driver supply which weighed on profitability during the year. However, Spyglass believes these investments have set up Lyft to generate more consistent earnings growth in 2023 and beyond. Momentive Global Inc., a developer of survey software, was a bottom contributor for the Fund in 2022. Broad-based macroeconomic uncertainty led to slower new deal activity and existing customers consuming a lower amount of existing survey credits. Peloton Interactive, Inc., a leading exercise equipment and media company, was a bottom contributor for the Fund in 2022. The Company brought on a new CEO who is pursuing a turnaround that is focused on reducing the expense base and reaccelerating revenue growth.

In 2022, rising inflation and rising interest rates were the primary focus of investors with the Federal Reserve delivering seven rate hikes totaling an increase of 4.25%. The Fed has not tightened rates this aggressively since the early 1980s. Across asset classes, this was a tough year to be an investor. Commodities were the only major asset class to achieve gains in 2022. Both bonds and equities lost value. However, this was the best year for Value's relative performance compared to Growth since the year 2000. The S&P 500 Value Index outperformed the Growth Index by more than 2400 basis points while the Russell 2000 Value Index outperformed the Growth Index by more than 1400 basis points. From a sector perspective, cyclical and defensive sectors led the way in 2022. In the S&P 500 Index and the Russell Midcap Growth Index, Energy stocks rose 64.6% and 59.1%, respectively, while Utilities rose 1.6% and 2.9%, respectively. No other sectors were positive for the year, but sectors such as Industrials and Materials only declined modestly relative to more growth-oriented sectors such as Technology, Communications, and Consumer Discretionary. Given this backdrop, which included fear of a recession, a ground war in Europe, and lingering effects of the COVID-19 pandemic, investor sentiment continued to be particularly bearish.

As long-term investors in rapidly growing companies, Spyglass typically utilizes time – often measured in years – for the fundamentals of our portfolio companies to evolve. Given the market environment in 2022, investors appeared defensive and seemed to gravitate quickly to companies with strong current earnings and lower P/E multiples. Low P/E multiples are often associated with safety and value; however, they also tend to be

------

associated with businesses that offer low levels of growth. While cyclical low-growth industries such as Energy, Industrials, and Materials outperformed in 2022 as investor dollars prioritized short-term safety, Spyglass historically does not invest in these sectors because the Spyglass research engine is built to capitalize on the opportunity to unlock potential alpha embedded in what we see as tomorrow's leading growth companies. We believe these companies will not only grow rapidly but also generate high levels of earnings and free cash flow. Spyglass seeks companies that grow their revenues, and ultimately their earnings, at approximately 20% per year on average. We invest in these companies until the stock price intercepts our calculated present value. The intention of the Spyglass Growth Fund is not to lose less money by owning stocks that might go down less, rather our objective is to drive capital appreciation by owning world class growth businesses where share price gains outrun the market averages over time.

As growth stocks came under pressure in 2022, the market seemed increasingly focused on interest rates, inflation, and the impact of a potential recession. Notably, the conversation around innovation in the economy faded into the background. At Spyglass, we are perpetually trying to find those companies that will benefit from an ever-evolving economy. The spring of 2023 will hopefully mark the end of a three-year economic episode that was dramatically impacted by the COVID-19 pandemic. The pandemic and the resulting turbulence—economic and social—have been enormous distractions from the progress in fields such as artificial intelligence and genomics when we look out. While we are not satisfied with the results of the last quarter or the last year, we remain as optimistic as ever that investing with a value orientation in rapidly growing companies, operating in dynamic sectors of the economy, and being led by entrepreneurs, will allow us to generate returns that exceed the long-term average returns of the market. Every day we are reminded that innovation changes the world. While the pessimists can sound smart, the future belongs to the optimists.

We want to thank you for your confidence in the Spyglass Growth Fund. We will continue to invest your money alongside ours, and we look forward to updating you at the end of 2023.

Sincerely,

Spyglass Capital Management, LLC

*SPY000121*

------

Disclosures:

The opinions expressed are subject to change, are not guaranteed and should not be considered investment advice. Fund holdings and/or sector allocations are subject to change at any time and are not recommendations to buy or sell any security. Please see Schedule of Investments for a complete list of holdings. Top ten holdings as of December 31, 2022: Ascendis Pharma A/S (6.94%); Affiliated Managers Group, Inc. (5.29%); GoDaddy, Inc. (5.27%); TransDigm Group, Inc. (5.26%); Nutanix, Inc. (5.15%); ZoomInfo Technologies Inc. (5.15%); Exact Sciences Corp. (4.99%); Five Below, Inc. (4.56%); Vail Resorts, Inc. (4.39%); and Leslie's, Inc. (4.38%).

*The Fund's investment objectives, risks, charges and expenses must be read and considered carefully before investing. The Prospectus contains this and other important information about the investment company. It may be obtained through this website, or a free hard-copy version is available by calling (toll free) 888-878-5680. Read the prospectus carefully before investing.*

Mutual fund investing involves risk. Principal loss is possible. The Fund is non-diversified, meaning it may focus its assets in fewer individual holdings than a diversified fund. Therefore, the Fund is more exposed to individual stock volatility than a diversified fund. Medium- and small-capitalization companies tend to have limited liquidity and greater price volatility than large-capitalization companies.

The Russell Midcap<sup>®</sup> Growth Index measures the performance of those Russell Midcap<sup>®</sup> companies with higher price/book ratios and higher forecasted growth values. The S&P 500<sup>®</sup> is widely regarded as the best single gauge of large-cap U.S. equities. The index measures the performance of the large-cap segment of the market. Considered to be a proxy of the U.S. equity market, the index is composed of 500 constituent companies. The price/earnings ratio is the ratio of a company's stock price to the company's earnings per share. The price-to-book ratio (P/B Ratio) is a ratio used to compare a stock's market value to its book value. An investment cannot be made directly in an index.

Performance of the Russell Midcap<sup>®</sup> Growth Index is included for informational purposes to show the general trend in the midcap equity market for the periods indicated and is not intended to imply that the portfolio was similar to the index either in composition or element of risk. The volatility of indices may be materially different from the performance of Spyglass' strategy. The Russell Midcap<sup>®</sup> Growth Index is an unmanaged stock market index that measures the performance of those Russell Midcap<sup>®</sup> companies. Investors cannot invest directly in an index; Index performance does not reflect trading commissions and costs. Due to these differences, comparison to an index should not be relied upon as an accurate measure of comparison.

On December 29, 2017, Spyglass Partners Fund LP, a limited partnership managed by the Advisor (the "Predecessor Partnership"), converted into the Institutional Shares class of the Fund by contributing all of its assets to the Fund in exchange for Institutional Shares of the Fund. The Predecessor Partnership was formed on October 1, 2015, to serve as a pooled investment vehicle for accredited investors, and since inception the Predecessor Partnership maintained investment policies, objectives, guidelines, and restrictions that were, in all material respects, equivalent to those of the Fund. From the date of inception through the time of the conversion, the Predecessor Partnership was managed by the Advisor and the same portfolio manager as the Fund. The conversion date was December 29, 2017 (inception) and the Fund commenced operations on January 2, 2018. The Fund's performance prior to 2018 is that of the Predecessor Partnership and the returns reflect the deduction of the 1% management fee and expenses, paid by the Predecessor

------

Partnership, without provision for state or local taxes. The performance includes gains or losses plus income and the reinvestment of all dividends and interest. Other than the Predecessor Partnership, the Advisor did not manage any accounts materially equivalent to the Fund during the period of the Predecessor Partnership's performance shown above. The Predecessor Partnership was not registered under the 1940 Act, and was not subject to certain investment limitations, diversification requirements, and other restrictions imposed by the 1940 Act and the Internal Revenue Code of 1986, as amended (the "Code"), which, if applicable, may have adversely affected its performance. For periods beginning January 1, 2018, the Fund's net performance is calculated on a daily basis and also includes a deduction of 1% management fee and is subject to a 1% expense cap, which differs in certain respects from the methods used to compute total returns for the Predecessor Partnership.

The Spyglass Growth Fund is distributed by: ALPS Distributors, Inc., member FINRA, an unaffiliated entity.

#### Performance Disclosure:
**The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost, and current performance may be higher or lower than the performance quoted. For performance data current to the most recent month end, please call 1.888.878.5680.**

Fee waiver language(can be shortened just keep the word "contractual" in shortened version):

Pursuant to a contractual operating expense limitation between Spyglass Capital Management LLC (the "Advisor"), the Fund's investment adviser, and the Fund, the Advisor has agreed to waive its management fees and/or reimburse Fund expenses to ensure that Total Annual Fund Operating Expenses (excluding any frontend or contingent deferred loads, Rule 12b-1 plan fees, shareholder servicing plan fees, taxes, leverage (i.e., any expenses incurred in connection with borrowings made by the Fund), interest (including interest incurred in connection with bank and custody overdrafts), brokerage commissions and other transactional expenses, expenses incurred in connection with any merger or reorganization, dividends or interest on short positions, acquired fund fees and expenses or extraordinary expenses such as litigation (collectively, "Excludable Expenses")) do not exceed 1.00% of the Fund's average daily net assets, through at least April 30, 2023, unless terminated sooner by, or with the consent of, the Trust's Board of Trustees (the "Board of Trustees" or the "Board"). To the extent the Fund incurs Excludable Expenses, Total Annual Fund Operating Expenses After Fee Waiver and/or Expense Reimbursement will exceed 1.00%. The Advisor may request recoupment of previously waived fees and paid expenses from the Fund for up to three years from the date such fees and expenses were waived or paid, if such reimbursement will not cause the Fund's total expense ratio to exceed the lesser of: (1) the expense limitation in place at the time of the waiver and/or expense payment; or (2) the expense limitation in place at the time of the recoupment.

------

#### Spyglass Growth Fund

---

| |
|:---|
| **INVESTMENT HIGHLIGHTS** |
| (Unaudited) |

---

#### Comparison of the Change in Value of a Hypothetical $100,000 Investment

#### in the Spyglass Growth Fund – Institutional Shares and

#### Russell Midcap Growth Index

![](sgf-linechart.jpg)

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Annualized Total Return Periods Ended** | One | Three | Five | Since Inception |
| **December 31, 2022:** | <u>Year</u> | <u>Year</u> | <u>Year</u> | <u>(10/1/2015)</u> |
| Spyglass Growth Fund – |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Institutional Shares<sup>(1)(2)</sup> | -47.23% | -7.17% | 3.73% | &nbsp;&nbsp;&nbsp;&nbsp;6.35% |
| Russell Midcap Growth Index | -26.72% | 3.85% | 7.64% | 10.18% |

---

Expense ratios\*: Gross 1.05%, Net 1.00% (Institutional Shares)

*Performance data quoted represents past performance; past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance of the Fund may be lower or higher than the performance quoted. Performance data current to the most recent month end may be obtained by calling 1-888-878-5680.*

This chart illustrates the performance of a hypothetical $100,000 investment made in the Fund on October 1, 2015, the Fund's inception date. Returns reflect the reinvestment of dividends and capital gain distributions. The performance data and expense ratios shown reflect a contractual fee waiver made by the Adviser, currently, through April 30, 2024. In the absence of fee waivers, returns would be reduced. The performance data and graph do not reflect the deduction of taxes that a shareholder may pay on dividends, capital gain distributions, or redemption of Fund shares. This chart does not imply any future performance.

\* The expense ratios presented are from the most recent prospectus. The expense ratio for the fiscal year ended December 31, 2022 was 1.09% (Gross); 1.00% (Net) for the Institutional Shares.

(1) Fund commenced operations on January 2, 2018.

(2) The performance data quoted for periods prior to January 2, 2018 is that of the Spyglass Partners Fund Limited Partnership (the "Partnership"). The Partnership commenced operations on October 1, 2015. The Partnership was not a registered mutual fund and was not subject to the same investments and tax restrictions as the Fund. If it had been, the Partnership's performance might have been lower.

------

#### Spyglass Growth Fund

---

| |
|:---|
| **SECTOR ALLOCATION OF PORTFOLIO ASSETS** |
| **at December 31, 2022** |

---

![](sgf-piechart.jpg)

Percentages represent market value as a percentage of net assets.

Note: For Presentation purposes, the Fund has grouped some of the industry categories for purposes of categorizing securities for compliance with Section 8(b)(1) of the Investment Company Act of 1940, as amended, the Fund uses more specific industry classifications.

------

---

| |
|:---|
| **SCHEDULE OF INVESTMENTS** |
| **at December 31, 2022** |

---

---

| | | |
|:---|:---|:---|
|  | **Number of** | |
| **COMMON STOCKS – 99.1%** | **Shares** | **Value** |
| **COMMUNICATION SERVICES – 17.5%** | | |
| Cable One, Inc. | 24836 | $17679755 |
| Match Group, Inc. (a) | 574058 | 23817666 |
| Roku, Inc. (a) | 299343 | 12183260 |
| Spotify Technology SA – ADR (a) | 278105 | 21956390 |
| ZoomInfo Technologies, Inc. (a) | 1051956 | 31674395 |
| **TOTAL COMMUNICATION SERVICES** |  | 107311466 |
| **CONSUMER DISCRETIONARY – 15.6%** |  |  |
| Five Below, Inc. (a) | 158354 | 28008072 |
| Leslie's, Inc. (a) | 2205054 | 26923709 |
| Peloton Interactive, Inc. (a) | 1778350 | 14120099 |
| Vail Resorts, Inc. | 113179 | 26976215 |
| **TOTAL CONSUMER DISCRETIONARY** |  | 96028095 |
| **FINANCIALS – 5.3%** |  |  |
| Affiliated Managers Group, Inc. | 205189 | 32508093 |
| **TOTAL FINANCIALS** |  | 32508093 |
| **HEALTH CARE – 18.9%** |  |  |
| Ascendis Pharma A/S – ADR (a) | 349291 | 42658910 |
| Exact Sciences Corp. (a) | 620686 | 30730164 |
| Pacira BioSciences, Inc. (a) | 425459 | 16426972 |
| Oak Street Health, Inc. (a) | 1222071 | 26286747 |
| **TOTAL HEALTH CARE** |  | 116102793 |
| **INDUSTRIALS – 9.4%** |  |  |
| Lyft, Inc. (a) | 2309239 | 25447814 |
| TransDigm Group, Inc. | 51332 | 32321194 |
| **TOTAL INDUSTRIALS** |  | 57769008 |

---

*The accompanying notes are an integral part of these financial statements.*

------

---

| |
|:---|
| **SCHEDULE OF INVESTMENTS (Continued)** |
| **at December 31, 2022** |

---

---

| | | |
|:---|:---|:---|
|  | **Number of** | |
| **COMMON STOCKS – 99.1% (Continued)** | **Shares** | **Value** |
| **INFORMATION TECHNOLOGY – 32.4%** | | |
| Affirm Holdings, Inc. (a) | 1639228 | $15851335 |
| AppLovin Corp. (a) | 1356972 | 14288915 |
| Datadog, Inc. (a) | 319613 | 23491556 |
| GoDaddy, Inc. (a) | 432792 | 32381497 |
| Momentive Global, Inc. (a) | 2449675 | 17147725 |
| Nutanix, Inc. (a) | 1219234 | 31761046 |
| Palo Alto Networks, Inc. (a) | 176963 | 24693417 |
| Pure Storage, Inc. (a) | 670288 | 17936907 |
| Splunk, Inc. (a) | 249533 | 21482296 |
| **TOTAL INFORMATION TECHNOLOGY** |  | 199034694 |
| **TOTAL COMMON STOCKS** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;(Cost $789,044,132) – 99.1% |  | 608754149 |
| Other Assets in Excess of Liabilities – 0.9% |  | 5783704 |
| **TOTAL NET ASSETS – 100.0%** |  | $614537853 |

---

Percentages are stated as a percent of net assets.

ADR – American Depositary Receipt

(a) Non-income producing security.

The Global Industry Classification Standard (GICS<sup>®</sup>) was developed by and/or is the exclusive property of MSCI, Inc. and Standard & Poor's Financial Services LLC ("S&P"). GICS is a service mark of MSCI and S&P and has been licensed for use by U.S. Bank Global Fund Services.

*The accompanying notes are an integral part of these financial statements.*

------

---

| |
|:---|
| **STATEMENT OF ASSETS AND LIABILITIES** |
| **at December 31, 2022** |

---

---

| | |
|:---|:---|
| **Assets:** | |
| Investments, at value (cost of $789,044,132) | $608754149 |
| Cash | 399759 |
| Receivables: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Securities sold | 12138722 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fund shares sold | 1913724 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividends Receivable | 221016 |
| Prepaid expenses | 30349 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total assets | 623457719 |
| **Liabilities:** |  |
| Payables: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Securities purchased | 6190835 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fund shares redeemed | 2101696 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Investment advisory fees | 482261 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Administration and fund accounting fees | 68701 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Custody fees | 14179 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfer agent fees and expenses | 28524 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other accrued expenses | 33670 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total liabilities | 8919866 |
| **Net assets** | $614537853 |
| **Net assets consist of:** |  |
| Paid in capital | $1404766153 |
| Total accumulated losses | (790228300) |
| Net assets | $614537853 |
| **Institutional Shares:** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net assets applicable to outstanding Institutional Shares | $614537853 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shares issued (Unlimited number of beneficial |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;interest authorized, $0.01 par value) | 65138803 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Net asset value, offering price and redemption price per share** | $9.43 |

---

*The accompanying notes are an integral part of these financial statements.*

------

---

| |
|:---|
| **STATEMENT OF OPERATIONS** |
| **For the Year Ended December 31, 2022** |

---

---

| | |
|:---|:---|
| **Investment income:** | |
| Dividends | $2855711 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total investment income | 2855711 |
| **Expenses:** |  |
| Investment advisory fees (Note 4) | 11958727 |
| Administration and fund accounting fees (Note 4) | 443291 |
| Transfer agent fees and expenses | 203895 |
| Federal and state registration fees | 148492 |
| Custody fees | 128002 |
| Reports to shareholders | 31094 |
| Legal fees | 24677 |
| Trustees' fees and expenses | 16213 |
| Audit fees | 14992 |
| Compliance expense | 12441 |
| Other | 34683 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total expenses before reimbursement from advisor | 13016507 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Expense reimbursement from advisor (Note 4) | (1050279) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net expenses | 11966228 |
| **Net investment loss** | (9110517) |
| **Realized and unrealized loss:** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized loss on investments | (543588532) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net change in unrealized depreciation on investments | (326034688) |
| **Net realized and unrealized loss** | (869623220) |
| **Net decrease in net assets resulting from operations** | $(878733737) |

---

*The accompanying notes are an integral part of these financial statements.*

------

**STATEMENTS OF CHANGES IN NET ASSETS**<br>

---

| | | |
|:---|:---|:---|
|  | **Year ended** | **Year Ended** |
|  | **December 31, 2022** | **December 31, 2021** |
| **Operations:** | | |
| Net investment loss | $(9110517) | $(21991524) |
| Net realized gain (loss) on investments | (543588532) | 209523057 |
| Net change in unrealized |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;appreciation (depreciation) on investments | (326034688) | (385280190) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Net decrease in net assets** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **&nbsp;&nbsp;&nbsp;&nbsp;resulting from operations** | (878733737) | (197748657) |
| **Distributions:** |  |  |
| Distributed earnings | (385085) | (292699584) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total distributions | (385085) | (292699584) |
| **Capital Share Transactions:** |  |  |
| Proceeds from shares sold | 502904743 | 1098995294 |
| Proceeds from shares issued to |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;holders in reinvestment of dividends | 301758 | 236144946 |
| Cost of shares redeemed | (1074273282) | (522730441) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Net increase (decrease) in net assets** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **&nbsp;&nbsp;&nbsp;&nbsp;from capital share transactions** | (571066781) | 812409799 |
| Total increase (decrease) in net assets | (1450185603) | 321961558 |
| **Net Assets:** |  |  |
| Beginning of year | 2064723456 | 1742761898 |
| End of year | $614537853 | $2064723456 |
| **Changes in Shares Outstanding:** |  |  |
| Shares sold | 38335470 | 48483426 |
| Shares issued to holders in |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;reinvestment of dividends | 31142 | 13579353 |
| Shares redeemed | (88718265) | (25097954) |
| Net increase (decrease) in shares outstanding | (50351653) | 36964825 |

---

*The accompanying notes are an integral part of these financial statements.*

------

**FINANCIAL HIGHLIGHTS**<br>

For a capital share outstanding throughout each period

#### Institutional Shares

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | | | | | **January 2, 2018\*** |
|  | **Year Ended** | **Year Ended** | **Year Ended** | **Year Ended** | **through** |
|  | **December 31,** | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
|  | **2022** | **2021** | **2020** | **2019** | **2018** |
| **Net Asset Value –** |  |  |  |  |  |
| **&nbsp;&nbsp;&nbsp;&nbsp;Beginning of Period** | $17.88 | $22.19 | $14.09 | $10.52 | $10.00 |
| **Income from** |  |  |  |  |  |
| **&nbsp;&nbsp;&nbsp;&nbsp;Investment Operations:** |  |  |  |  |  |
| Net investment loss<sup>1</sup> | (0.10) | (0.22) | (0.17) | (0.10) | (0.10 |
| Net realized and unrealized |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;gain (loss) on investments | (8.34) | (1.28) | 8.87 | 3.89 | 1.14 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total from |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;investment operations | (8.44) | (1.50) | 8.70 | 3.79 | 1.04 |
| **Less Distributions:** |  |  |  |  |  |
| Dividends from |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;net realized gains | (0.01) | (2.81) | (0.60) | (0.22) | (0.52 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total distributions | (0.00) | (2.81) | (0.60) | (0.22) | (0.52 |
| **Net Asset Value –** |  |  |  |  |  |
| **&nbsp;&nbsp;&nbsp;&nbsp;End of Period** | $9.43 | $17.88 | $22.19 | $14.09 | $10.52 |
| Total Return  | (47.23)% | (6.42 )% | 61.82% | 36.03% | 10.36 |
| **Ratios and Supplemental Data:** |  |  |  |  |  |
| Net assets, end of |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;period (thousands) | $614538 | $2064723 | $1742762 | $253018 | $41530 |
| Ratio of operating expenses |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;to average net assets: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Before reimbursements | 1.09% | 1.05% | 1.09% | 1.21% | 1.78 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; After reimbursements | 1.00% | 1.00% | 1.00% | 1.00% | 1.00 |
| Ratio of net investment loss |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;to average net assets: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Before reimbursements | (0.85)% | (1.00)% | (1.04)% | (0.97)% | (1.61 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; After reimbursements | (0.76)% | (0.95)% | (0.95)% | (0.76)% | (0.83 |
| Portfolio turnover rate  | 54% | 51% | 38% | 39% | 66 |

---

---

| | |
|:---|:---|
| \* | Commencement of operations for Institutional Shares was January 2, 2018. |
| <sup>+</sup> | Annualized |
| ^ | Not Annualized |
| <sup>1</sup> | The net investment loss per share was calculated using the average shares outstanding method. |

---

*The accompanying notes are an integral part of these financial statements.*

------

#### Spyglass Growth Fund

---

| |
|:---|
| **NOTES TO FINANCIAL STATEMENTS** |
| **at December 31, 2022** |

---

#### NOTE 1 – ORGANIZATION
The Spyglass Growth Fund (the "Fund") is a series of Manager Directed Portfolios (the "Trust"). The Trust is registered under the Investment Company Act of 1940, as amended (the "1940 Act"), and was organized as a Delaware statutory trust on April 4, 2006. The Fund is an open-end investment management company and is a non-diversified series of the Trust. The Fund acquired the assets of Spyglass Partners Fund, LP, a Delaware investment limited partnership (the "Predecessor Private Fund"), in a tax-free conversion completed at the close of business on December 29, 2017. The Fund did not have any operations prior to December 29, 2017 other than those relating to organizational matters and registration of its shares under applicable securities law. The Fund commenced operations on January 2, 2018, and currently only offers Institutional Shares. The Predecessor Private Fund had an investment objective and investment policies that were, in all material respects, equivalent to those of the Fund. However, the Predecessor Private Fund was not registered as an investment company under the 1940 Act, and was not subject to certain investment limitations, diversification requirements, liquidity requirements and other restrictions imposed by the 1940 Act and Subchapter M of the Internal Revenue Code of 1986, as amended (the "Code"). Upon completion of the conversion, the net assets of the Fund were $16,225,831. The number of shares of the Fund issued in connection with the conversion was 1,622,583, and the amount of net unrealized gains on the portfolio securities transferred to the Fund was $2,060,757. Spyglass Capital Management LLC (the "Advisor") serves as the investment advisor to the Fund. As an investment company, the Fund follows the investment company accounting and reporting guidance of the Financial Accounting Standards Board ("FASB") Accounting Standard Codification Topic 946 Financial Services – Investment Companies. The investment objective of the Fund is to seek long term capital appreciation.

#### NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES
The following is a summary of significant accounting policies consistently followed by the Fund. These policies are in conformity with U.S. generally accepted accounting principles ("GAAP").

---

| | |
|:---|:---|
| A. | *Security Valuation:* All investments in securities are recorded at their estimated fair value, as described in Note 3. |
| B. | *Federal Income Taxes:* It is the Fund's policy to comply with the requirements of Subchapter M of the Internal Revenue Code applicable to regulated investment companies and to distribute substantially all of its taxable income to its shareholders. Therefore, no federal income or excise tax provisions are required. |
|  | The Fund recognizes the tax benefits of uncertain tax positions only where the position is "more likely than not" to be sustained assuming examination by tax authorities. Management has analyzed the Fund's tax positions and has concluded that no liability for unrecognized tax benefits should be recorded related to uncertain tax positions to be taken or expected to be taken on a tax return. The tax |

---

------

#### Spyglass Growth Fund

---

| |
|:---|
| **NOTES TO FINANCIAL STATEMENTS (Continued)** |
| **at December 31, 2022** |

---

---

| | |
|:---|:---|
|  | returns for the Fund for the prior three fiscal years are open for examination. The Fund identifies its major tax jurisdictions as U.S. Federal and the state of Delaware. |
| C. | *Securities Transactions, Income and Distributions:* Securities transactions are accounted for on the trade date. Realized gains and losses on securities sold are determined on the basis of identified cost. Interest income is recorded on an accrual basis. Dividend income and distributions to shareholders are recorded on the ex-dividend date. Withholding taxes on foreign dividends have been provided for in accordance with the Fund's understanding of the applicable country's tax rules and rates. |
|  | The Fund distributes substantially all of its net investment income, if any, and net realized capital gains, if any, annually. Distributions from net realized gains for book purposes may include short-term capital gains. All short-term capital gains are included in ordinary income for tax purposes. The amount of dividends and distributions to shareholders from net investment income and net realized capital gains is determined in accordance with federal income tax regulations, which may differ from GAAP. To the extent these book/tax differences are permanent, such amounts are reclassified within the capital accounts based on their federal tax treatment. |
|  | The Fund is charged for those expenses that are directly attributable to it, such as investment advisory, custody and transfer agent fees. Expenses that are not attributable to a Fund are typically allocated among the funds in the Trust proportionately based on allocation methods approved by the Board of Trustees (the "Board"). Common expenses of the Trust are typically allocated among the funds in the Trust based on a fund's respective net assets, or by other equitable means. |
| D. | *Use of Estimates:* The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets during the reporting period. Actual results could differ from those estimates. |
| E. | *Reclassification of Capital Accounts:* GAAP requires that certain components of net assets relating to permanent differences be reclassified between financial and tax reporting. These reclassifications have no effect on net assets or net asset value per share. |
| F. | *Events Subsequent to the Fiscal Period End:* In preparing the financial statements as of December 31, 2022 and through the date the financial statements were available to be issued, management considered the impact of subsequent events for potential recognition or disclosure in the financial statements and had concluded that no additional disclosures are necessary. |
| G. | *Recent Accounting Pronouncements and Rule Issuances:* In October 2020, the SEC adopted new regulations governing the use of derivatives by registered |

---

------

---

| |
|:---|
| **NOTES TO FINANCIAL STATEMENTS (Continued)** |
| **at December 31, 2022** |

---

---

| |
|:---|
| investment companies ("Rule 18f-4"). Rule 18f-4 will impose limits on the amount of derivatives a Fund can enter into, eliminate the asset segregation framework currently used by funds to comply with Section 18 of the 1940 Act, and require funds whose use of derivatives is greater than a limited specified amount to establish and maintain a comprehensive derivatives risk management program and appoint a derivatives risk manager. Funds will be required to comply with Rule 18f-4 by August 19, 2022. It is not currently clear what impact, if any, Rule 18f-4 will have on the availability, liquidity or performance of derivatives. Management is currently evaluating the potential impact of Rule 18f-4 on the Fund. When fully implemented, Rule 18f-4 may require changes in how a Fund uses derivatives, adversely affect the Fund's performance and increase costs related to the Fund's use of derivatives. As of December 31, 2022, the Fund did not invest in any derivatives. |
| In December 2020, the SEC adopted a new rule providing a framework for fund valuation practices ("Rule 2a-5"). Rule 2a-5 establishes requirements for determining fair value in good faith for purposes of the 1940 Act. Rule 2a-5 will permit fund boards to designate certain parties to perform fair value determinations, subject to board oversight and certain other conditions. Rule 2a-5 also defines when market quotations are "readily available" for purposes of the 1940 Act and the threshold for determining whether a fund must fair value a security. In connection with Rule 2a-5, the SEC also adopted related recordkeeping requirements and is rescinding previously issued guidance, including with respect to the role of a board in determining fair value and the accounting and auditing of fund investments. The Funds will be required to comply with the rules by September 8, 2022. Management is currently assessing the potential impact of the new rules on the Funds' financial statements. |

---

#### NOTE 3 – SECURITIES VALUATION
The Fund has adopted authoritative fair value accounting standards which establish an authoritative definition of fair value and set out a hierarchy for measuring fair value. These standards require additional disclosures about the various inputs and valuation techniques used to develop the measurements of fair value, a discussion of changes in valuation techniques and related inputs during the period and expanded disclosure of valuation levels for major security types. These inputs are summarized in the three broad levels listed below:

---

| | |
|:---|:---|
| Level 1 – | Unadjusted, quoted prices in active markets for identical assets or liabilities that the Fund has the ability to access at the date of measurement. |
| Level 2 – | Other significant observable inputs (including, but not limited to, quoted prices in active markets for similar instruments, quoted prices in markets that are not active for identical or similar instruments, and model-derived valuations in which all significant inputs and significant value drivers are |

---

------

#### Spyglass Growth Fund

---

| |
|:---|
| **NOTES TO FINANCIAL STATEMENTS (Continued)** |
| **at December 31, 2022** |

---

---

| | |
|:---|:---|
|  | observable in active markets, such as interest rates, prepayment speeds, credit risk curves, default rates, and similar data). |
| Level 3 – | Significant unobservable inputs for the asset or liability, to the extent relevant observable inputs are not available, representing the Fund's own assumptions about the assumptions a market participant would use in valuing the asset or liability, and would be based on the best information available. |

---

Following is a description of the valuation techniques applied to the Fund's major categories of assets and liabilities measured at fair value on a recurring basis.

*Equity Securities:* Equity securities, including common stocks, preferred stocks, foreign-issued common stocks, exchange-traded funds, closed-end mutual funds and real estate investment trusts (REITs), that are primarily traded on a national securities exchange shall be valued at the last sale price on the exchange on which they are primarily traded on the day of valuation or, if there has been no sale on such day, at the mean between the bid and asked prices. Securities primarily traded in the NASDAQ Global Market System for which market quotations are readily available shall be valued using the NASDAQ Official Closing Price ("NOCP"). If the NOCP is not available, such securities shall be valued at the last sale price on the day of valuation, or if there has been no sale on such day, at the mean between the bid and asked prices. Over-the-counter securities that are not traded on a listed exchange are valued at the last sale price in the over-the-counter market. Over-the-counter securities which are not traded in the NASDAQ Global Market System shall be valued at the mean between the bid and asked prices. To the extent these securities are actively traded and valuation adjustments are not applied, they are categorized in Level 1 of the fair value hierarchy.

*Registered Investment Companies:* Investments in registered investment companies (e.g., mutual funds) are generally priced at the ending NAV provided by the applicable registered investment company's service agent and will be classified in Level 1 of the fair value hierarchy.

*Short-Term Debt Securities:* Debt securities, including short-term debt instruments having a maturity of less than 60 days, are valued at the evaluated mean price supplied by an approved pricing service. Pricing services may use various valuation methodologies including matrix pricing and other analytical pricing models as well as market transactions and dealer quotations. In the absence of prices from a pricing service, the securities will be priced in accordance with the procedures adopted by the Board. Short-term securities are generally classified in Level 1 or Level 2 of the fair market hierarchy depending on the inputs used and market activity levels for specific securities.

The Board has delegated day-to-day valuation issues to a Valuation Committee of the Trust which, as of June 30, 2022, was comprised of officers of the Trust. The function of the Valuation Committee is to value securities where current and reliable market quotations are not readily available, or the closing price does not represent fair value, by following procedures approved by the Board. These procedures consider many factors, including the

------

---

| |
|:---|
| **NOTES TO FINANCIAL STATEMENTS (Continued)** |
| **at December 31, 2022** |

---

type of security, size of holding, trading volume and news events. All actions taken by the Valuation Committee are subsequently reviewed and ratified by the Board.

Depending on the relative significance of the valuation inputs, fair valued securities may be classified in either level 2 or level 3 of the fair value hierarchy.

The inputs or methodology used for valuing securities are not an indication of the risk associated with investing in those securities. The following is a summary of the fair valuation hierarchy of the Fund's securities as of December 31, 2022:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Level 1** | **Level 2** | **Level 3** | **Total** |
| **Common Stocks** | | | | |
| Communication Services | $107311466 | $— | $— | $107311466 |
| Consumer Discretionary | 96028095 |  |  | 96028095 |
| Financials | 32508093 |  |  | 32508093 |
| Health Care | 116102793 |  |  | 116102793 |
| Industrials | 57769008 |  |  | 57769008 |
| Information Technology | 199034694 |  |  | 199034694 |
| **Total Common Stocks** | 608754149 |  |  | 608754149 |
| **Total Investments in Securities** | $608754149 | $— | $— | $608754149 |

---

#### NOTE 4 – INVESTMENT ADVISORY FEE AND OTHER TRANSACTIONS WITH AFFILIATES
For the fiscal year ended December 31, 2022, the Advisor provided the Fund with investment management services under an Investment Advisory Agreement. The Advisor furnishes all investment advice, office space, and facilities, and provides most of the personnel needed by the Fund. As compensation for its services, the Advisor is entitled to a monthly fee at an annual rate of 1.00% for the Spyglass Growth Fund based upon the average daily net assets of the Fund. For the fiscal year ended December 31, 2022, the Fund incurred $11,958,727 in advisory fees.

The Fund is responsible for its own operating expenses. The Advisor has contractually agreed to waive its management fees and/or absorb expenses of the Fund to ensure that the total annual operating expenses [excluding front-end or contingent deferred loads, Rule 12b-1 plan fees, shareholder servicing plan fees, taxes, leverage, interest, brokerage commissions and other transactional expenses, expenses in connection with a merger or reorganization, dividends or interest on short positions, acquired fund fees and expenses or extraordinary expenses (collectively, "Excludable Expenses")] do not exceed the following amounts of the average daily net assets for the Institutional Shares:

#### Spyglass Growth Fund

---

| | |
|:---|:---|
| Institutional Shares | 1.00% |

---

For the fiscal year ended December 31, 2022, the Advisor reduced its fees and absorbed Fund expenses in the amount of $1,050,279 for the Fund. The waivers and

------

---

| |
|:---|
| **NOTES TO FINANCIAL STATEMENTS (Continued)** |
| **at December 31, 2022** |

---

reimbursements will remain in effect through April 30, 2024 unless terminated sooner by, or with the consent of, the Board.

The Advisor may request recoupment of previously waived fees and paid expenses in any subsequent month in the three-year period from the date of the management fee reduction and expense payment if the aggregate amount actually paid by the Fund toward the operating expenses for such fiscal year (taking into account the reimbursement) will not cause the Fund's expenses to exceed the lesser of: (1) the expense limitation in place at the time of the management fee reduction and expense payment; or (2) the expense limitation in place at the time of the reimbursement. Any such reimbursement is also contingent upon Board of Trustees review and approval at the time the reimbursement is made. Such reimbursement may not be paid prior to the Fund's payment of current ordinary operating expenses. Cumulative expenses subject to recapture pursuant to the aforementioned conditions expire as follows:

---

| | | |
|:---|:---|:---|
| **<u>Amount</u>** | **<u>Amount</u>** | **<u>Expiration</u>** |
|  | 732,905 | 12/31/2023 |
|  | 1,213,828 | 12/31/2024 |
|  | 1,050,279 | 12/31/2025 |

---

U.S. Bancorp Fund Services, LLC, doing business as U.S. Bank Global Fund Services, LLC ("Fund Services" or the "Administrator") acts as the Fund's Administrator under an Administration Agreement. The Administrator prepares various federal and state regulatory filings, reports and returns for the Fund; prepares reports and materials to be supplied to the Trustees; monitors the activities of the Fund's custodian, transfer agent and accountants; coordinates the preparation and payment of the Fund's expenses and reviews the Fund's expense accruals. Fund Services also serves as the fund accountant and transfer agent to the Fund. Vigilant Compliance, LLC serves as the Chief Compliance Officer to the Fund. U.S. Bank N.A., an affiliate of Fund Services, serves as the Fund's custodian. For the fiscal year ended December 31, 2022, the Fund incurred the following expenses for administration, fund accounting, transfer agency and custody fees:

---

| | |
|:---|:---|
| Administration & fund accounting | $443291 |
| Custody | $128002 |
| Transfer agency | $203895 |

---

At December 31, 2022, the Fund had payables due to Fund Services for administration, fund accounting and transfer agency fees and to U.S. Bank N.A. for custody fees in the following amounts:

---

| | |
|:---|:---|
| Administration & fund accounting | $68701 |
| Custody | $14179 |
| Transfer agency | $28524 |

---

------

---

| |
|:---|
| **NOTES TO FINANCIAL STATEMENTS (Continued)** |
| **at December 31, 2022** |

---

ALPS Distributor, Inc. (the "Distributor") acts as the Fund's principal underwriter in a continuous public offering of the Fund's shares.

Certain officers of the Fund are employees of the Administrator and are not paid any fees by the Fund for serving in such capacities.

#### NOTE 5 – SECURITIES TRANSACTIONS
For the fiscal year ended December 31, 2022, the cost of purchases and the proceeds from sales of securities, excluding short-term securities, were as follows:

---

| | | |
|:---|:---|:---|
|  | **Purchases** | **Sales** |
| Spyglass Growth Fund | $651665252 | $1219410820 |

---

There were no purchases or sales of long-term U.S. Government securities.

#### NOTE 6 – INCOME TAXES AND DISTRIBUTIONS TO SHAREHOLDERS
As of December 31, 2022, the components of accumulated earnings/(losses) on a tax basis were as follows:

---

| | |
|:---|:---|
| Cost of investments<sup>(a)</sup> | 932744181 |
| Gross unrealized appreciation | 101131704 |
| Gross unrealized depreciation | (425121736) |
| Net unrealized depreciation | (323990032) |
| Undistributed ordinary income |  |
| Undistributed long-term capital gain |  |
| Total distributable earnings |  |
| Other accumulated losses | (466238268) |
| Total accumulated earnings | (790228300) |

---

<sup>(a)</sup> The difference between the book basis and tax basis net unrealized depreciation and cost is attributable primarily to wash sales.

For tax purposes, the Fund had no post October capital loss deferrals at December 31, 2022.

As of December 31, 2022, the Fund had long-term capital losses in the amount of $75,362,962 and short-term tax basis capital losses in the amount of $387,539,553 to offset future capital gains.

The tax character of distributions paid during the year ended December 31, 2022 and the year ended December 31, 2021 was as follows:

---

| | | |
|:---|:---|:---|
|  | **Fiscal Year Ended** | **Fiscal Year Ended** |
|  | **December 31, 2022** | **December 31, 2021** |
| Ordinary income | $385085 | $120508378 |
| Long-Term Capital Gains |  | 172191206 |
| Total | $385085 | $292699584 |

---

------

#### Spyglass Growth Fund

---

| |
|:---|
| **NOTES TO FINANCIAL STATEMENTS (Continued)** |
| **at December 31, 2022** |

---

For the fiscal year ended December 31, 2022, the effect of permanent "book/tax" reclassifications resulted in increases and decreases to components of the Funds' net assets as follows:

---

| | | |
|:---|:---|:---|
|  | **Total Accumulated** | **Paid-In** |
|  | **Earnings/Loss** | **Capital** |
| Spyglass Growth Fund | $9495602 | $(9495602) |

---

#### NOTE 7 – PRINCIPAL RISKS
Below are summaries of some, but not all, of the principal risks of investing in the Fund, each of which could adversely affect the Fund's NAV, market price, yield, and total return. Further information about investment risks is available in the Fund's prospectus and Statement of Additional Information.

*General Market Risk; Recent Market Events:* The value of the Fund's shares will fluctuate based on the performance of the Fund's investments and other factors affecting the securities markets generally. Certain investments selected for the Fund's portfolio may be worth less than the price originally paid for them, or less than they were worth at an earlier time. The value of the Fund's investments may go up or down, sometimes dramatically and unpredictably, based on current market conditions, such as real or perceived adverse political or economic conditions, inflation, changes in interest rates, lack of liquidity in the fixed income markets or adverse investor sentiment.

U.S. and international markets have experienced volatility in recent months and years due to a number of economic, political and global macro factors, including the impact of the coronavirus (COVID-19) global pandemic, which has resulted in a public health crisis, business interruptions, growth concerns in the U.S. and overseas, layoffs, rising unemployment claims, changed travel and social behaviors and reduced consumer spending. The effects of COVID-19 may lead to a substantial economic downturn or recession in the U.S. and global economies, the recovery from which is uncertain and may last for an extended period of time.

*Equity Market Risk:* Equity securities are susceptible to general stock market fluctuations due to economic, market, political and issuer-specific considerations and to potential volatile increases and decreases in value as market confidence in and perceptions of their issuers change.

*Small-Cap and Mid-Cap Company Risk:* Small-Cap and Mid-Cap companies often have less predictable earnings, more limited product lines, markets, distribution channels or financial resources, and the management of such companies may be dependent upon one or few key people. The market movements of equity securities of these companies may be more abrupt and volatile than the market movements of equity securities of larger, more established companies, or the stock market in general. Because of these movements, and because small-cap and mid-cap companies tend to be bought and sold less often and in smaller amounts, they are generally less liquid than the equity securities of larger companies.

------

#### Spyglass Growth Fund

---

| |
|:---|
| **NOTES TO FINANCIAL STATEMENTS (Continued)** |
| **at December 31, 2022** |

---

*Management Risk:* The ability of the Fund to meet its investment objective is directly related to the Advisor's management of the Fund. The value of your investment in the Fund may vary with the effectiveness of the Advisor's research, analysis and asset allocation among portfolio securities. If the investment strategies do not produce the expected results, the value of your investment could be diminished or even lost entirely.

*Non-Diversified Fund Risk:* Because the Fund is "non-diversified," it may invest a greater percentage of its assets in the securities of a single issuer. As a result, a decline in the value of an investment in a single issuer could cause the Fund's overall value to decline to a greater degree than if the Fund held a more diversified portfolio.

*Sector Emphasis Risk:* Although the Advisor selects stocks based on their individual merits, some economic sectors will represent a larger portion of the Fund's overall investment portfolio than other sectors. Potential negative market or economic developments affecting one of the larger sectors could have a greater impact on the Fund than on a fund with fewer holdings in that sector.

*Information Technology Sector Risk:* Technology companies face intense competition, which may have an adverse effect on profit margins. Technology companies may have limited product lines, markets, financial resources or personnel. The products of technology companies may face obsolescence due to rapid technological developments and frequent new product introduction, unpredictable changes in growth rates, and competition for the services of qualified personnel. Information technology companies may be smaller and less experienced companies, with limited product lines, markets or financial resources and fewer experienced management or marketing personnel. Information technology companies may be subject to additional risks, including loss of patent, copyright, and trademark protections, as well as evolving industry standards.

*REIT Risk:* A REIT's share price may decline because of adverse developments affecting the real estate industry, including changes in interest rates. The returns from REITs may trail returns from the overall market. The Fund's investments in REITs may be subject to special tax rules, or a particular REIT may fail to qualify for the favorable federal income tax treatment applicable to REITs, the effect of which may have adverse tax consequences for the Fund and shareholders.

*Cash and Cash Equivalent Risk:* At various times, the Fund may have cash balances that exceed federally insured limits. It is the opinion of management that the solvency of the financial institutions are not of a particular concern at this time.

#### NOTE 8 – GUARANTEES AND INDEMNIFICATIONS
In the normal course of business, the Fund enters into contracts that contain a variety of representations and warranties and which provide general indemnifications. The Fund's maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Fund that have not yet occurred. However, based on experience, the Fund expects the risk of loss to be remote.

------

#### Spyglass Growth Fund

**REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**<br>

#### To the Board of Trustees of Manager Directed Portfolios

#### and the Shareholders of Spyglass Growth Fund
<u>Opinion on the Financial Statements</u>

We have audited the accompanying statement of assets and liabilities of Spyglass Growth Fund, a series of shares of beneficial interest in Manager Directed Portfolios (the "***Fund***"), including the schedule of investments, as of December 31, 2022, and the related statement of operations for the year then ended, the statements of changes in net assets for each of the years in the two-year period then ended and the financial highlights for each of the years in the four-year period then ended and for the period from January 2, 2018 (commencement of operations) through December 31, 2018, and the related notes (collectively referred to as the "***financial statements***"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Fund as of December 31, 2022, and the results of its operations for the year then ended, the changes in its net assets for each of the years in the two-year period then ended, and its financial highlights for each of the years in the four-year period then ended and for the period from January 2, 2018 through December 31, 2018, in conformity with accounting principles generally accepted in the United States of America.

<u>Basis for Opinion</u>

These financial statements are the responsibility of the Fund's management. Our responsibility is to express an opinion on the Fund's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("***PCAOB***") and are required to be independent with respect to the Fund in accordance with the U.S. federal securities law and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Fund is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risk of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our procedures included confirmation of securities owned as of December 31, 2022 by correspondence with the custodian, brokers, or by other appropriate auditing procedures where replies from brokers were not received. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

![](bbdllp4-signature.jpg)

#### BBD, LLP
*We have served as the auditor of one or more of the Funds in the Manager Directed Portfolios since 2007.*

#### Philadelphia, Pennsylvania

#### March 1, 2023

------

#### Spyglass Growth Fund

---

| |
|:---|
| **EXPENSE EXAMPLE** |
| **December 31, 2022 (Unaudited)** |

---

As a shareholder of the Fund, you incur two types of costs: (1) transaction costs; and (2) ongoing costs, including management fees; and other Fund expenses. This Example is intended to help you understand your ongoing costs (in dollars) of investing in the Fund and to compare these costs with the ongoing costs of investing in other mutual funds.

The Example is based on an investment of $1,000 invested at the beginning of the period indicated and held for the entire period from July 1, 2022 to December 31, 2022 for the Institutional Shares.

#### Actual Expenses
The information in the table under the heading "Actual" provides information about actual account values and actual expenses. You may use the information in these columns together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the row entitled "Expenses Paid During Period" to estimate the expenses you paid on your account during this period. There are some account fees that are charged to certain types of accounts, such as Individual Retirement Accounts (generally, a $15 fee is charged to the account annually) that would increase the amount of expenses paid on your account. The example below does not include portfolio trading commissions and related expenses and other extraordinary expenses as determined under generally accepted accounting principles.

#### Hypothetical Example for Comparison Purposes
The information in the table under the heading "Hypothetical (5% return before expenses)" provides information about hypothetical account values and hypothetical expenses based on the Fund's actual expense ratio and assumed rate of return of 5% per year before expenses, which is not the Fund's actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in the Fund and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds. As noted above, there are some account fees that are charged to certain types of accounts that would increase the amount of expense paid on your account.

Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transaction costs. Therefore, the information under the heading "Hypothetical (5% return before expenses)" is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds. In addition, if these transactional costs were included, your costs would have been higher.

------

#### Spyglass Growth Fund

---

| |
|:---|
| **EXPENSE EXAMPLE (Continued)** |
| **December 31, 2022 (Unaudited)** |

---

---

| | | | |
|:---|:---|:---|:---|
|  | **Beginning** | **Ending** | **Expenses Paid** |
|  | **Account Value** | **Account Value** | **During Period** |
|  | **<u>7/1/2022</u>** | **<u>12/31/2022</u>** | **<u>7/1/2022 – 12/31/2022<sup>(1)</sup></u>** |
| **Actual** |  |  |  |
| Institutional Shares | $1000.00 | $910.80 | $4.82 |
| **Hypothetical (5% return** |  |  |  |
| **&nbsp;&nbsp;&nbsp;&nbsp;before expenses)** |  |  |  |
| Institutional Shares | $1000.00 | $1020.16 | $5.09 |

---

(1) Expenses are equal to the Institutional Shares' annualized expense ratio of 1.00% multiplied by the average account value over the period, multiplied by 184/365 (to reflect the period).

------

---

| |
|:---|
| **STATEMENT REGARDING LIQUIDITY RISK MANAGEMENT PROGRAM** |
| (Unaudited) |

---

In accordance with Rule 22e-4 under the Investment Company Act of 1940, as amended, the Fund, a series of Manager Directed Portfolios (the "Trust"), has adopted and implemented a liquidity risk management program tailored specifically to the Fund (the "Program"). The Program seeks to promote effective liquidity risk management for the Fund and to protect Fund shareholders from dilution of their interests. The Board has designated the Fund's investment adviser to serve as the administrator of the Program (the "Program Administrator"). Personnel of the Fund's investment adviser conduct the day-to-day operation of the Program pursuant to policies and procedures administered by the Program Administrator. The Program Administrator is required to provide a written annual report to the Board and the chief compliance officer of the Trust regarding the adequacy and effectiveness of the Program, including the operation of the Fund's highly liquid investment minimum, and any material changes to the Program.

Under the Program, the Program Administrator manages the Fund's liquidity risk, which is the risk that the Fund could not meet shareholder redemption requests without significant dilution of remaining shareholders' interests in the Fund. The Program assesses liquidity risk under both normal and reasonably foreseeable stressed market conditions. This risk is managed by monitoring the degree of liquidity of the Fund's investments, limiting the amount of the Fund's illiquid investments, and utilizing various risk management tools and facilities available to the Fund for meeting shareholder redemptions, among other means. The Program Administrator's process of determining the degree of liquidity of the Fund's investments is supported by one or more third-party liquidity assessment vendors.

On November 18, 2022, the Board reviewed the Program Administrator's assessment of the operation and effectiveness of the Program for the period December 15, 2021 through September 30, 2022 (the "Report") and a memorandum regarding the Report prepared by the Trust's chief compliance officer. The Report noted that the Fund's portfolio is expected to continue to primarily hold highly liquid investments and the determination that the Fund be designated as a "primarily highly liquid fund" (as defined in Rule 22e-4) remains appropriate. The Fund can therefore continue to rely on the exclusion in Rule 22e-4 from the requirements to determine and review a highly liquid investment minimum for the Fund and to adopt policies and procedures for responding to a highly liquid investment minimum shortfall. The Report noted that there were no breaches of the Fund's restriction on holding illiquid investments exceeding 15% of its net assets during the review period. The Report confirmed that the Fund's investment strategy was appropriate for an open-end management investment company. The Report also indicated that no material changes had been made to the Program during the review period.

The Program Administrator determined that the Fund is reasonably likely to be able to meet redemption requests without adversely affecting non-redeeming Fund shareholders through significant dilution. The Program Administrator concluded that the during the review period, the Program was adequately designed and effectively operating to monitor the liquidity risk to the Fund, taking into account the size of the Fund, the type of business conducted, and other relevant factors.

------

---

| |
|:---|
| **NOTICE TO SHAREHOLDERS** |
| **at December 31, 2022 (Unaudited)** |

---

#### How to Obtain a Copy of the Fund's Proxy Voting Policies
A description of the policies and procedures that the Fund uses to determine how to vote proxies relating to portfolio securities is available without charge, upon request, by calling 1-888-878-5680 or on the U.S. Securities and Exchange Commission's ("SEC") website at http://www.sec.gov.

#### How to Obtain a Copy of the Fund's Proxy Voting Records for the most recent 12-Month Period Ended June 30
Information regarding how the Fund voted proxies relating to portfolio securities during the most recent 12-month period ended June 30 is available no later than August 31 without charge, upon request, by 1-888-878-5680. Furthermore, you can obtain the Fund's proxy voting records on the SEC's website at http://www.sec.gov.

#### Quarterly Filings on Form N-PORT
The Fund files its complete schedule of portfolio holdings with the SEC for the first and third quarters of each fiscal year on Part F of Form N-PORT. The Fund's Part F of Form N-PORT is available on the SEC's website at http://www.sec.gov. Information included in the Fund's Part F of Form N-PORT is also available, upon request, by calling 1-888-878-5680.

#### Qualified Dividend Income/Dividends Received Deduction
For the fiscal year ended December 31, 2022 certain dividends paid by the Funds may be subject to a maximum tax rate of 15%, as provided for by the Jobs and Growth Tax Relief Reconciliation Act of 2003. The percentage of dividends declared from ordinary income designated as qualified dividend income was as follows:

---

| | | |
|:---|:---|:---|
| Spyglass Growth Fund | 0.48 | % |

---

For corporate shareholders, the percent of ordinary income distributions qualifying for the corporate dividends received deduction for the fiscal year ended December 31, 2022 was as follows:

---

| | | |
|:---|:---|:---|
| Spyglass Growth Fund | 0.48 | % |

---

The percentage of taxable ordinary income distributions that are designated as short-term capital gain distributions under Internal Revenue Section 871(k)(2)(C) for each Fund were as follows:

---

| | | |
|:---|:---|:---|
| Spyglass Growth Fund | 100.00 | % |

---

------

#### Spyglass Growth Fund

---

| |
|:---|
| **TRUSTEES AND OFFICERS** |
| (Unaudited) |

---

The business and affairs of the Trust are managed under the oversight of the Board, subject to the laws of the State of Delaware and the Trust's Agreement and Declaration of Trust. The Board, as of January 1, 2021, is currently comprised of four trustees who are not interested persons of the Trust within the meaning of the 1940 Act (the "Independent Trustees"). The Trustees are responsible for deciding matters of overall policy and overseeing the actions of the Trust's service providers. The officers of the Trust conduct and supervise the Trust's daily business operations.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  |  |  | **Number of** |  |
|  |  |  | **Funds** | **Other** |
|  | **Position(s) Held** |  | **in Fund** | **Directorships** |
| **Name,** | **with the Trust** |  | **Complex** | **Held by Trustee** |
| **Year of Birth** | **and Length of** | **Principal Occupation(s)** | **Overseen by** | **During the Past** |
| **<u>and Address<sup>(1)</sup></u>** | **<u>Time Served<sup>(2)</sup></u>** | **<u>During the Past Five Years</u>** | **<u>Trustee<sup>(3)</sup></u>** | **<u>Five Years</u>** |
| INDEPENDENT TRUSTEES |  |  |  |  |
| Gaylord B. Lyman | Trustee and | Senior Portfolio Manager, | 10 |  |
| (Born 1962) | Audit Committee | Affinity Investment Advisors, |  |  |
|  | Chairman, since | LLC, since 2017; Managing |  |  |
|  | April 2015 | Director of Kohala Capital |  |  |
|  |  | Partners, LLC (2011 – 2016). |  |  |
| Scott Craven Jones | Trustee since | Managing Director, Carne Global | 10 | Trustee, Madison |
| (Born 1962) | July 2016 and | Financial Services (US) LLC |  | Funds, since 2019 |
|  | Lead Independent | (a provider of independent |  | (18 portfolios); |
|  | Trustee since | governance and distribution |  | Trustee, XAI |
|  | May 2017 | support for the asset management |  | Octagon Floating |
|  |  | industry), since 2013; interim |  | Rate & |
|  |  | Managing Director, Park Agency, |  | Alternative |
|  |  | Inc., since 2020. |  | Income Term |
|  |  |  |  | Trust, since 2017 |
|  |  |  |  | (2 portfolios); |
|  |  |  |  | Director, |
|  |  |  |  | Guestlogix Inc. |
|  |  |  |  | (a provider of |
|  |  |  |  | ancillary-focused |
|  |  |  |  | technology to the |
|  |  |  |  | travel industry) |
|  |  |  |  | (2015 – 2016). |

---

------

---

| |
|:---|
| **TRUSTEES AND OFFICERS (Continued)** |
| (Unaudited) |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  |  |  | **Number of** |  |
|  |  |  | **Funds** | **Other** |
|  | **Position(s) Held** |  | **in Fund** | **Directorships** |
| **Name,** | **with the Trust** |  | **Complex** | **Held by Trustee** |
| **Year of Birth** | **and Length of** | **Principal Occupation(s)** | **Overseen by** | **During the Past** |
| **<u>and Address<sup>(1)</sup></u>** | **<u>Time Served<sup>(2)</sup></u>** | **<u>During the Past Five Years</u>** | **<u>Trustee<sup>(3)</sup></u>** | **<u>Five Years</u>** |
| Lawrence T. | Trustee since | Senior Vice President and Chief | 10 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Greenberg | July 2016 | Legal Officer, The Motley Fool |  |  |
| (Born 1963) |  | Holdings, Inc., since 1996; |  |  |
|  |  | Venture Partner and General |  |  |
|  |  | Counsel, Motley Fool Ventures |  |  |
|  |  | LP, since 2018; Manager, Motley |  |  |
|  |  | Fool Wealth Management, LLC, |  |  |
|  |  | since 2013; Adjunct Professor, |  |  |
|  |  | Washington College of Law, |  |  |
|  |  | American University, since 2006; |  |  |
|  |  | General Counsel Motley Fool |  |  |
|  |  | Asset Management, LLC |  |  |
|  |  | (2008 – 2019). |  |  |
| James R. Schoenike | Trustee since | Distribution consultant since | 10 |  |
| (Born 1959) | July 2016<sup>(4)</sup> | 2018, President and CEO, Board |  |  |
|  |  | of Managers, Quasar Distributors, |  |  |
|  |  | LLC (2013 – 2018). |  |  |

---

<sup>(1)</sup> The address of each Trustee as it relates to the Trust's business is c/o U.S. Bank Global Fund Services, 615 East Michigan Street, Milwaukee, WI 53202.

<sup>(2)</sup> Each Trustee serves during the continued lifetime of the Trust until he dies, resigns, is declared bankrupt or incompetent by a court of competent jurisdiction, or is removed.

<sup>(3)</sup> The Trust currently has nine active portfolios.

<sup>(4)</sup> Prior to January 1, 2021, Mr. Schoenike was considered to be an "interested person" of the Fund by virtue of his previous position as President of Quasar Distributors, LLC.

As of the date of this report, no Independent Trustee nor any of his immediate family members (i.e., spouse or dependent children) serves as an officer or director or is an employee of the Advisor, Sub-Advisor or Distributor, or any of their respective affiliates, nor is such person an officer, director or employee of any company controlled by or under common control with such entities.

------

---

| |
|:---|
| **TRUSTEES AND OFFICERS (Continued)** |
| (Unaudited) |

---

---

| | | |
|:---|:---|:---|
| **Name,** | **Position(s) Held with** |  |
| **Year of Birth** | **Trust and Length** |  |
| **<u>and Address</u>** | **<u>of Time Served<sup>(3)</sup></u>** | **<u>Principal Occupation(s) During Past Five Years</u>** |
| OFFICERS |  |  |
| Scott M. Ostrowski<sup>(1)</sup> | President and Principal | Senior Vice President, Compliance and |
| (Born 1980) | Executive Officer, since | Administration, Fund Services, since 2006. |
|  | August 10, 2021 |  |
| Ryan Frank<sup>(1)</sup> | Treasurer, and | Vice President, Fund Services, since 2008. |
| (Born 1985) | Principal Financial |  |
|  | Officer, since |  |
|  | August 17, 2022 |  |
| Colton W. Scarmardo<sup>(1)</sup> | Assistant Treasurer, | Fund Administrator, Compliance and Administration, |
| (Born 1997) | since May 11, 2021 | Fund Services, since 2019; Business Administration |
|  |  | Student, 2015-2019, MBA obtained May 2022. |
| Justin Dausch<sup>(2)</sup> | Chief Compliance | Director, Vigilant, since 2017; Compliance Associate, |
| (Born 1989) | Officer and Anti-Money | HSBC (investment banking company), 2015 – 2017. |
|  | Laundering Compliance |  |
|  | Officer, since |  |
|  | January 1, 2020 |  |
| Alyssa M. Bernard<sup>(1)</sup> | Vice President and | Assistant Vice President, Compliance and |
| (Born 1988) | Secretary, since | Administration, Fund Services, since 2018; Attorney, |
|  | August 20, 2019<sup>(4)</sup> | Mutual Fund Disclosure, Waddell & Reed Financial, |
|  |  | Inc., 2017 – 2018; Attorney, Corporate Governance, |
|  |  | American Century Companies, Inc., 2014 – 2017. |
| Isabella K. Zoller<sup>(1)</sup> | Assistant Secretary, | Assistant Vice President, Fund Services, since 2021; |
| (Born 1994) | since February 15, 2022 | Regulatory Administration Attorney, Fund Services, |
|  |  | since 2019; Regulatory Administration Intern, Fund |

---

<sup>(1)</sup> The mailing address of this officer is: 615 East Michigan Street, Milwaukee, Wisconsin 53202.

<sup>(2)</sup> The mailing address of this officer is: 223 Wilmington West Chester Pike, Suite 216, Chadds Ford, Pennsylvania 19317.

<sup>(3)</sup> Each officer is elected annually and serves until his or her successor has been duly elected and qualified.

<sup>(4)</sup> Ms. Bernard has served as Vice President of the Trust, in addition to her other positions held with the Trust, since May 11, 2021.

The Statement of Additional Information includes additional information about the Fund's Trustees and Officers and is available, without charge, upon request by calling 1-800-497-2960.

------

---

| |
|:---|
| **APPROVAL OF THE SPYGLASS GROWTH FUND** |
| **INVESTMENT ADVISORY AGREEMENT (Unaudited)** |

---

The Board of Trustees (the "Board") of Manager Directed Portfolios (the "Trust") met on November 18, 2022 to consider the renewal of the Investment Advisory Agreement (the "Advisory Agreement") between the Trust, on behalf of the Spyglass Growth Fund (the "Fund"), a series of the Trust, and the Fund's investment adviser, Spyglass Capital Management, LLC ("Spyglass"). The Trustees had previously met at a special meeting held on October 18, 2022 to discuss the renewal of the Advisory Agreement. Prior to these meetings, the Trustees requested and received materials to assist them in considering the approval of the Advisory Agreement. The materials provided contained information with respect to the factors enumerated below, including a copy of the Advisory Agreement, a memorandum prepared by the Trust's outside legal counsel discussing the Board's fiduciary obligations and factors relevant to the renewal of the Advisory Agreement, comparative information relating to the performance of the Fund against the Fund's peer group and benchmark index, Spyglass' Form ADV, due diligence materials provided by Spyglass, including information regarding Spyglass' compliance program, personnel and financial condition, profitability information, and other pertinent information. The Board also reviewed the advisory fee payable by the Fund under the Advisory Agreement; the expense limitation agreement between Spyglass and the Trust, on behalf of the Fund; and comparative fee and expense information as reported by Morningstar.

The Trustees met with the officers of the Trust and legal counsel to discuss the information provided and also met in executive session with legal counsel to the Independent Trustees to review their duties in considering the Advisory Agreement and the information provided. The Trustees noted that they had met with representatives from Spyglass in-person earlier in the year to discuss Spyglass' investment strategy for the Fund, the Fund's performance, and various business, personnel, marketing and compliance updates. The Board also took into account information routinely provided at quarterly meetings throughout the year regarding the quality of services provided by Spyglass, the performance of the Fund, brokerage and trading, Fund expenses, asset flows, compliance issues and related matters.

Based on their evaluation of the information provided as part of the October and November meetings, as well as information provided over the course of the year, the Trustees, all of whom are not "interested persons" of the Trust, as that term is defined in the Investment Company Act of 1940, as amended (the "Independent Trustees"), approved the continuation of the Advisory Agreement for an additional one-year term. Below is a summary of the material factors considered by the Board and the conclusions that formed the basis for the Board's approval of the Advisory Agreement.

1. NATURE, EXTENT AND QUALITY OF SERVICES PROVIDED TO THE FUND

The Trustees considered the nature, extent and quality of services provided by Spyglass to the Fund. The Board considered the services provided by Spyglass, including investment and market research, security selection, compliance services and Fund marketing, as well as portfolio management, trading, and proxy voting services. The Board considered Spyglass' investment strategy for the Fund and information regarding

------

---

| |
|:---|
| **APPROVAL OF THE SPYGLASS GROWTH FUND** |
| **INVESTMENT ADVISORY AGREEMENT (Unaudited) (Continued)** |

---

Spyglass' risk management practices. The Trustees considered that Spyglass and its personnel were responsible for the day-to-day management of the Fund, noting the qualifications, experience, and responsibilities of James Robillard, the Fund's portfolio manager, and other key personnel at Spyglass and its service providers involved in the day-to-day activities of the Fund. The Trustees also noted any services that extended beyond portfolio management, including the firm's brokerage practices. The Trustees considered additional information provided by Spyglass in a due diligence questionnaire, including information about Spyglass' compliance program and the operation of Spyglass' business continuity plan. The Trustees concluded that Spyglass had sufficient quality and depth of personnel, resources, investment methods and compliance policies and procedures essential to performing its duties under the Advisory Agreement, and that the nature, overall quality and extent of services provided to the Fund were satisfactory.

2. INVESTMENT PERFORMANCE OF THE FUND

The Trustees discussed the performance of the Fund for the year-to-date, one-year, three-year, five-year, and since inception periods ended June 30, 2022. In assessing the quality of the portfolio management services delivered by Spyglass, the Trustees considered the short-term and longer-term performance of the Fund on both an absolute basis and in comparison to the Fund's benchmark index, the Russell Mid-Cap Growth Index. The Trustees also compared the Fund's performance to a peer group of U.S. mid-cap growth funds (the "Morningstar Peer Group").

The Trustees noted that the Fund underperformed the Russell Mid-Cap Growth Index for all time periods reviewed. The Trustees noted that the Fund underperformed the average return of its Morningstar Peer Group for the one-year, three-year, and five-year periods. The Board considered Spyglass' commentary regarding the investment environment and the market conditions that negatively impacted the Fund's performance for recent time periods, as well as the concentrated nature of the Fund's portfolio as compared to the benchmark index. The Board further considered the nearly two decades of experience of the Fund's portfolio manager, who has developed and implements the Spyglass growth strategy. The Trustees reviewed the Fund's performance relative to Spyglass' composite of other separately managed accounts managed with investment strategies substantially similar to the Fund, and noted the performance of the Fund was relatively in line with the performance of the separately managed accounts.

After considering all of the information, the Trustees concluded that the Fund and its shareholders were likely to benefit from Spyglass' continued management.

3. ADVISORY FEE, COSTS OF SERVICES PROVIDED AND PROFITS REALIZED BY THE ADVISER

The Trustees considered the cost of services provided by Spyglass and Spyglass' advisory fee, including a review of comparative fee and expense information. The Trustees considered the net expense ratio of the Fund relative to the Morningstar Peer Group

------

---

| |
|:---|
| **APPROVAL OF THE SPYGLASS GROWTH FUND** |
| **INVESTMENT ADVISORY AGREEMENT (Unaudited) (Continued)** |

---

average, as well as the fee waivers and expense reimbursements previously provided by Spyglass. The Trustees also considered Spyglass' financial statements and a profitability analysis prepared by Spyglass based on the fees payable under the Advisory Agreement.

The Trustees noted that the Fund's contractual management fee of 1.00% was higher than the Morningstar Peer Group average. The Trustees further noted that the total net expense ratio for the Institutional Shares and Retail Shares (not currently offered) were higher than the Morningstar Peer Group average. The Board noted that, pursuant to a contractual operating expense limitation agreement between Spyglass and the Fund, Spyglass has agreed to waive its management fees and/or reimburse Fund expenses to ensure that total annual fund operating expenses (excluding Rule 12b-1 plan fees, shareholder servicing plan fees and other excludable expenses) do not exceed 1.00% of the Fund's average daily net assets, through at least April 30, 2024, unless terminated sooner by, or with the consent of, the Board. The Trustees also considered Spyglass' commentary regarding the Fund's advisory fee and the fee structure for its separately managed accounts that are similar to the Fund in terms of investment strategy.

The Trustees concluded that the Fund's expenses and the management fees paid to Spyglass were fair and reasonable in light of the quality of services provided to the Fund. The Trustees concluded that Spyglass' level of profitability from its relationship with the Fund was reasonable.

4. EXTENT OF ECONOMIES OF SCALE AS THE FUND GROWS

The Trustees considered the structure of the Fund's management fee with respect to potential economies of scale. The Trustees noted that the Fund's management fee structure did not contain any breakpoint reductions as the Fund's assets grow in size but considered that Spyglass has been waiving fees or reimbursing expenses since the Fund's inception and that Spyglass pays all ordinary Fund expenses other than its advisory fee. The Trustees concluded that the current fee structure was reasonable and reflects a sharing of economies of scale between Spyglass and the Fund at the Fund's current asset level.

5. BENEFITS DERIVED FROM THE RELATIONSHIP WITH THE FUND

The Trustees considered the direct and indirect benefits that could be realized by Spyglass from its association with the Fund. The Trustees concluded that the benefits Spyglass may receive, such as soft dollar research, appear to be reasonable and may benefit the Fund.

CONCLUSION

No single factor was determinative of the Board's decision to approve the continuation of the Advisory Agreement; rather, the Board based its determination on the total mix of information available to it. Based on a consideration of the above factors in their totality, the Trustees, all of whom are Independent Trustees, approved the continuation of the Advisory Agreement for an additional one-year term as being in the best interests of the Fund and its shareholders.

------

---

| |
|:---|
| **NOTICE OF PRIVACY POLICY AND PRACTICES** |
| (Unaudited) |

---

Protecting the privacy of Fund shareholders is important to us. The following is a description of the practices and policies through which we protect the privacy and security of your non-public personal information.

#### What Information We Collect
We collect and maintain information about you so that we can open and maintain your account in the Fund and provide various services to you. We collect non-public personal information about you from the following sources:

• information we receive about you on applications or other forms;

• information you give us orally; and

• information about your transactions with us or others.

The types of non-public personal information we collect and share can include:

• social security number;

• account balances;

• account transactions;

• transaction history;

• wire transfer instructions; and

• checking account information.

#### <br>

#### What Information We Disclose
We do not disclose any non-public personal information about shareholders or former shareholders of the Fund without the shareholder's authorization, except as permitted by law or in response to inquiries from governmental authorities. We may share information with affiliated parties and unaffiliated third parties with whom we have contracts for servicing the Fund. We will provide unaffiliated third parties with only the information necessary to carry out their assigned responsibility.

#### How We Protect Your Information
All shareholder records will be disposed of in accordance with applicable law. We maintain physical, electronic and procedural safeguards to protect your non-public personal information and require third parties to treat your non-public personal information with the same high degree of confidentiality.

In the event that you hold shares of the Fund through a financial intermediary, including, but not limited to, a broker-dealer, bank or trust company, the privacy policy of your financial intermediary would govern how your non-public personal information would be shared with unaffiliated third parties.

If you have any questions or concerns regarding this notice or our Privacy Policy, please contact us at 1-888-878-5680.

------

(This Page Intentionally Left Blank.)

------

#### Investment Advisor
Spyglass Capital Management, LLC

One Letterman Drive

Building C, Suite 3600

San Francisco, CA 94129

#### Distributor
ALPS Distributor, Inc.

11290 Broadway, Suite 1000

Denver, CO 80203

#### Transfer Agent
U.S. Bancorp Fund Services, LLC

615 East Michigan Street

Milwaukee, WI 53202

1-888-878-5680

#### Custodian
U.S. Bank National Association

Custody Operations

1555 North River Center Drive, Suite 302

Milwaukee, WI 53212

#### Independent Registered Public Accounting Firm
BBD, LLP

1835 Market Street, 3rd Floor

Philadelphia, PA 19103

#### Legal Counsel
Godfrey & Kahn S.C.

833 East Michigan Street, Suite 1800

Milwaukee, WI 53202

This report is intended for shareholders of the Fund and may not be used as sales literature unless preceded or accompanied by a current prospectus.

Past performance results shown in this report should not be considered a representation of future performance. Share price and returns will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Statements and other information herein are dated and are subject to change.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Not Applicable.

#### Item 2. Code of Ethics.

The registrant has adopted a code of ethics that applies to the registrant's principal executive officer and principal financial officer. The registrant has not made any substantive amendments to its code of ethics during the period covered by this report. The registrant has not granted any waivers from any provisions of the code of ethics during the period covered by this report.

*A copy of the registrant's Code of Ethics is filed herewith.*

#### Item 3. Audit Committee Financial Experts.

The registrant's Board of Trustees has determined that there are at least two audit committee financial experts serving on its audit committee. Messrs. Gaylord B. Lyman and Scott C. Jones are the "audit committee financial experts" and are considered to be "independent" as each term is defined in Item 3 of Form N-CSR.

#### Item 4. Principal Accountant Fees and Services.

The registrant has engaged its principal accountant to perform audit services, audit-related services, tax services and other services during the past two fiscal years. "Audit services" refer to performing an audit of the registrant's annual financial statements or services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for those fiscal years. "Audit-related services" refer to the assurance and related services by the principal accountant that are reasonably related to the performance of the audit. "Tax services" refer to professional services rendered by the principal accountant for tax compliance, tax advice, and tax planning. There were no "other services" provided by the principal accountant. The following table details the aggregate fees billed or expected to be billed for each of the last two fiscal years for audit fees, audit-related fees, tax fees and other fees by the principal accountant.

---

| | | |
|:---|:---|:---|
|  | FYE 12/31/2022 | FYE 12/31/2021 |
| Audit Fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $12000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $12000 |
| Audit-Related Fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; N/A | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; N/A |
| Tax Fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $3000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $3000 |
| All Other Fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; N/A | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; N/A |

---

The audit committee has adopted pre-approval policies and procedures that require the audit committee to pre-approve all audit and non-audit services of the registrant, including services provided to any entity affiliated with the registrant.

The percentage of fees billed by BBD, LLP applicable to non-audit services pursuant to waiver of pre-approval requirement were as follows:

---

| | | |
|:---|:---|:---|
|  | FYE 12/31/2022 | FYE 12/31/2021 |
| Audit-Related Fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0% |
| Tax Fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0% |
| All Other Fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0% |

---

All of the principal accountant's hours spent on auditing the registrant's financial statements were attributed to work performed by full-time permanent employees of the principal accountant.

The following table indicates the non-audit fees billed or expected to be billed by the registrant's accountant for services to the registrant and to the registrant's investment adviser (and any other controlling entity, etc.—not sub-adviser) for the last two years. The audit committee of the Board of Trustees has considered whether the provision of non-audit services that were rendered to the registrant's investment adviser is compatible with maintaining the principal accountant's independence and has concluded that the provision of such non-audit services by the accountant has not compromised the accountant's independence.

<u> Non-Audit Related Fees </u> <u> FYE 12/31/2022 </u> <u> FYE 12/31/2021 </u> <br> Registrant N/A N/A <br> <u> Registrant's Investment Adviser </u> <u> N/A </u> <u> N/A </u>

The registrant has not been identified by the U.S. Securities and Exchange Commission as having filed an annual report issued by a registered public accounting firm branch or office that is located in a foreign jurisdiction where the Public Company Accounting Oversight Board is unable to inspect or completely investigate because of a position taken by an authority in that jurisdiction.

The registrant is not a foreign issuer.

#### Item 5. Audit Committee of Listed Registrants.

(a) Not applicable to registrants who are not listed issuers (as defined in Rule 10A-3 under the Securities Exchange Act of 1934).

(b) Not Applicable.

#### Item 6. Investments.

&nbsp;&nbsp;&nbsp;&nbsp;(a) Schedule of Investments is included as part of the report to shareholders filed under Item 1 of this Form.

&nbsp;&nbsp;&nbsp;&nbsp;(b) Not Applicable.

#### Item 7. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.

Not applicable to open-end investment companies.

#### Item 8. Portfolio Managers of Closed-End Management Investment Companies.

Not applicable to open-end investment companies.

#### Item 9. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.

Not applicable to open-end investment companies.

#### Item 10. Submission of Matters to a Vote of Security Holders.

There have been no material changes to the procedures by which shareholders may recommend nominees to the Registrant's Board of Trustees.

#### Item 11. Controls and Procedures.

&nbsp;&nbsp;&nbsp;&nbsp;(a) The Registrant's President/Principal Executive Officer and Treasurer/Principal Financial Officer have reviewed the Registrant's disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940,
 as amended, (the "Act")) as of a date within 90 days of the filing of this report, as required by Rule 30a-3(b) under the Act and Rules 13a-15(b) or 15d-15(b) under the Securities Exchange Act of 1934. Based on their review, such
 officers have concluded that the disclosure controls and procedures are effective in ensuring that information required to be disclosed in this report is appropriately recorded, processed, summarized and reported and made known to them by
 others within the Registrant and by the Registrant's service provider.

&nbsp;&nbsp;&nbsp;&nbsp;(b) There were no changes in the Registrant's internal control over financial reporting (as defined in Rule 30a-3(d) under the Act) that occurred during the fourth fiscal quarter of the period covered by this report that has materially
 affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting.

#### Item 12. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.

Not applicable to open-end investment companies.

#### Item 13. Exhibits.

&nbsp;&nbsp;&nbsp;&nbsp;(a) [(1) *Any code of ethics or amendment thereto, that is subject to the disclosure required by Item 2, to the extent that the registrant intends to satisfy Item 2 requirements through filing an exhibit.* Filed herewith.](sgf-ex99codeeth.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[(2) *A separate certification for each principal executive and principal financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.* Filed herewith.](sgf-ex99cert302.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) *Any written solicitation to purchase securities under Rule 23c-1 under the Act sent or given during the period covered by the report by or on behalf of the registrant to 10 or more persons.* Not applicable to open-end investment companies.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) *Change in the registrant's independent public accountant.* There was no change in the registrant's independent public accountant for the period covered by this report

&nbsp;&nbsp;&nbsp;&nbsp;(b) [*Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.* Furnished herewith.](sgf-ex99cert906.htm)

------

#### SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Registrant) <u>Manager Directed Portfolios</u> 

By (Signature and Title)\* <u>/s/ Scott M. Ostrowski</u>

<br> &nbsp;&nbsp;&nbsp;&nbsp;Scott M. Ostrowski, President/

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Principal Executive Officer

Date <u>3/17/2023</u> 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, as amended, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By (Signature and Title)\* <u>/s/ Scott M. Ostrowski</u>

<br> &nbsp;&nbsp;&nbsp;&nbsp;Scott M. Ostrowski, President/

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Principal Executive Officer

Date <u>3/17/2023</u> <br>

By (Signature and Title)\* <u>/s/ Ryan Frank</u>

<br> &nbsp;&nbsp;&nbsp;&nbsp;Ryan Frank, Treasurer/

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Principal Financial Officer

Date <u>3/17/2023</u> <br>

\* Print the name and title of each signing officer under his or her signature.

## Ex-99.Code

#### Exhibit A

#### Manager Directed Portfolios

#### Code of Ethics for Principal Executive and Financial Officers

**I. COVERED OFFICERS/ PURPOSE OF THE CODE**

This code of ethics (the "Code") for Manager Directed Portfolios (the "Trust") applies to the Trust's Principal Executive Officer and Principal Financial Officer (the "Covered Officers," each of whom are set forth in Exhibit A) for the purpose of promoting:

**A.** honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;

**B.** full, fair, accurate, timely and understandable disclosure in reports and documents that the Trust files with or submits to the Securities and Exchange Commission (the "SEC") and in other public communications made by the Trust;

**C.** compliance with applicable laws and governmental rules and regulations;

**D.** the prompt internal reporting of violations of the Code to an appropriate person or persons identified in the Code; and

**E.** accountability for adherence to the Code.

Each Covered Officer should adhere to a high standard of business ethics and should be sensitive to situations that may give rise to actual as well as apparent conflicts of interest.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**II.** **COVERED OFFICERS SHOULD HANDLE ETHICALLY ACTUAL AND APPARENT CONFLICTS OF INTEREST** 

Overview. A "conflict of interest" occurs when a Covered Officer's private interest interferes with the interests of or his service to the Trust. For example, a conflict of interest would arise if a Covered Officer or a member of his family receives improper personal benefits as a result of his position with the Trust.

Certain conflicts of interest arise out of the relationships between Covered Officers and the Trust and are already subject to conflict of interest provisions in the Investment Company Act of 1940 (the "1940 Act") and the Investment Advisers Act of 1940 (the "Advisers Act"). For example, Covered Officers may not individually engage in certain transactions (such as the purchase or sale of securities or other property) with the Trust because of their status as "affiliated persons" of the Trust. The Trust's and the investment adviser's compliance programs and procedures are designed to prevent or identify and correct violations of these provisions. This Code does not and is not intended to repeat or replace these programs and procedures, and such conflicts fall outside of the parameters of this Code.

Although typically not presenting an opportunity for improper personal benefit, conflicts arise from or as a result of the contractual relationship between the Trust and the investment adviser of which the Covered Officers are also officers or employees. As a result, this Code recognizes that the Covered Officers will in the normal course of their duties (whether formally for the Trust or for the adviser or for both) be involved in establishing policies and implementing decisions that will have different effects on the adviser and the Trust. The participation of the Covered Officers in such activities is inherent in the contractual relationship between the Trust and the adviser and is consistent with the performance by the Covered Officers of their duties as officers of the Trust. Thus, if performed in conformity with the provisions of the 1940 Act and the Advisers Act, such activities will be deemed to have been handled ethically. In addition, it is recognized by the Trust's Board of Trustees ("Board") that the Covered Officers may also be officers or employees of one or more other investment companies covered by this or other codes.

Other conflicts of interest are covered by the Code, even if such conflicts of interest are not subject to the provisions of the 1940 Act and the Advisers Act. The following list provides examples of conflicts of interest under the Code, but Covered Officers should keep in mind that these examples are not exhaustive. The overarching principle is that the personal interest of a Covered Officer should not be placed improperly before the interest of the Trust.

Each Covered Officer must:

**A.** not use his personal influence or personal relationships improperly to influence investment decisions or financial reporting by the Trust whereby the Covered Officer would benefit personally to the detriment of the Trust;

**B.** not cause the Trust to take action, or fail to take action, for the individual personal benefit of the Covered Officer rather than the benefit the Trust; and

**C.** not use material nonpublic knowledge of portfolio transactions made or contemplated for the Trust to trade personally or cause others to trade personally in contemplation of the market effect of such transactions.

There are some conflict of interest situations that may be discussed with counsel if material. Examples of these include:

**A.** service as a director on the board of any public or private company;

**B.** the receipt of any non-nominal gifts;

**C.** the receipt of any entertainment from any company with which the Trust has current or prospective business dealings unless such entertainment is business-related, reasonable in cost, appropriate as to time and place, and not so frequent as to raise any question of impropriety;

**D.** any ownership interest in, or any consulting or employment relationship with, any of the Trust's service providers, other than its investment adviser, principal underwriter, administrator or any affiliated persons thereof; and

**E.** a direct or indirect financial interest in commissions, transaction charges or spreads paid by the Trust for effecting portfolio transactions or for selling or redeeming shares other than an interest arising from the Covered Officer's employment, such as compensation or equity ownership.

**III. DISCLOSURE AND COMPLIANCE**

**A.** Each Covered Officer should familiarize himself with the disclosure requirements generally applicable to the Trust;

**B.** each Covered Officer should not knowingly misrepresent, or cause others to misrepresent, facts about the Trust to others, whether within or outside the Trust, including to the Trust's Trustees and auditors, governmental regulators, and self-regulatory organizations;

**C.** each Covered Officer should, to the extent appropriate within his area of responsibility, consult with other officers and employees of the Trust and the adviser with the goal of promoting full, fair, accurate, timely and understandable disclosure in the reports and documents the Trust files with or submit to the SEC and in other public communications made by the Trust; and

**D.** it is the responsibility of each Covered Officer to promote compliance with the standards and restrictions imposed by applicable laws rules and regulations.

**IV. REPORTING AND ACCOUNTABILITY**

Each Covered Officer must:

**A.** upon adoption of the Code (or thereafter as applicable, upon becoming a Covered Officer), affirm in writing to the Board that he has received, read, and understands the Code (See Exhibit B);

**B.** annually thereafter affirm to the Board that he has complied with the requirements of the Code (See Exhibit B);

**C.** not retaliate against any other Covered Officer or any employee of the Trust or their affiliated persons for reports of potential violations that are made in good faith; and

**D.** notify the Trust's compliance officer promptly if he knows of any violation of this Code. Failure to do so is itself a violation of this Code.

The compliance officer is responsible for applying this Code to specific situations in which questions are presented under it and has the authority to interpret this Code in any particular situation. However, any approvals or waivers sought by the Covered Officer will be considered by the Board.

The Trust will follow these procedures in investigating and enforcing this Code:

**A.** The compliance officer will take all appropriate action to investigate any potential violations reported to him.

**B.** If, after such investigation, the compliance officer believes that no violation has occurred, the compliance officer is not required to take any further action.

**C.** Any matter that the compliance officer believes is a violation will be reported to the Board.

**D.** If the Board concurs that a violation has occurred, it will consider appropriate action, which may include review of and appropriate modifications to applicable policies and procedures; notification to appropriate personnel of the investment adviser or its board; or a recommendation to dismiss the Covered Officer.

**E.** The Board will be responsible for granting waivers, as appropriate.

**F.** Any changes to or waivers of this Code will, to the extent required, be disclosed as provided by SEC rules.

**V. OTHER POLICIES AND PROCEDURES**

This Code shall be the sole code of ethics adopted by the Trust for purposes of Section 406 of the Sarbanes-Oxley Act and the rules and forms applicable to registered investment companies thereunder. Insofar as other policies or procedures of the Trust, the Trust's adviser, principal underwriter, or other service providers govern or purport to govern the behavior or activities of the Covered Officers who are subject to this Code, they are superseded by this Code to the extent that they overlap or conflict with the provisions of this Code. The Trust's and its investment adviser's codes of ethics under Rule 17j-1 under the 1940 Act and the adviser's more detailed policies and procedures are separate requirements applying to the Covered Officers and others and are not part of this Code.

**VI. AMENDMENTS**

Any amendments to this Code, other than amendments to Exhibit A, must be approved or ratified by a majority vote of the Board, including a majority of independent Trustees.

**VII. CONFIDENTIALITY**

All reports and records prepared or maintained pursuant to this Code will be considered confidential and shall be maintained and protected accordingly. Except as otherwise required by law or this Code, such matters shall not be disclosed to anyone other than the Board and its counsel.

**VIII. INTERNAL USE**

The Code is intended solely for the internal use by the Trust and does not constitute an admission, by or on behalf of any company, as to any fact, circumstance, or legal conclusion.

The Board of Trustees of

Manager Directed Portfolios

#### Adopted: November, 2016

## Ex-99.Cert

#### CERTIFICATIONS

I, Scott M. Ostrowski, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this report on Form N-CSR of Manager Directed Portfolios;

&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
 misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if
 the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over
 financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: <u>3/17/2023</u>  | <u>/s/ Scott M. Ostrowski</u><br> Scott M. Ostrowski<br> President/Principal Executive Officer |

---

------

I, Ryan Frank, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this report on Form N-CSR of Manager Directed Portfolios;

&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
 misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if
 the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over
 financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: <u>3/17/2023</u>  | <u>/s/ Ryan Frank</u><br> Ryan Frank<br> Treasurer/Principal Financial Officer |

---

## Exhibit 99.906

#### Certification Pursuant to Section 906 of the Sarbanes-Oxley Act

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned officers of the Manager Directed Portfolios, does hereby certify, to such officer's knowledge, that the report on Form N-CSR of the Manager Directed Portfolios for the year ended December 31, 2022 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as applicable, and that the information contained in the Form N-CSR fairly presents, in all material respects, the financial condition and results of operations of the Manager Directed Portfolios for the stated period.

---

| | |
|:---|:---|
| <u>/s/ Scott M. Ostrowski</u><br> Scott M. Ostrowski<br> President/Principal Executive Officer,<br> Manager Directed Portfolios<br>| <u>/s/ Ryan Frank</u><br> Ryan Frank<br> Treasurer/Principal Financial Officer,<br> Manager Directed Portfolios<br>|
| Dated: <u>3/17/2023</u>  | Dated:<u> </u><u>3/17/2023</u>  |

---

This statement accompanies this report on Form N-CSR pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed as filed by Manager Directed Portfolios for purposes of Section 18 of the Securities Exchange Act of 1934.

<br>